Found 14 of ic50 for monomerid = 50155773 TargetLysine-specific histone demethylase 1A/REST corepressor 1(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: 0.380nMAssay Description:Inhibition of recombinant human KDM1A/CoREST complex expressed in Escherichia coli using [Lys(Me1)4]-Histone H3 (1 to 21 residues)-GGK(biotin) as sub...More data for this Ligand-Target Pair
TargetREST corepressor 1 [4-485](Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: 6.5nMAssay Description:Inhibition of human recombinant KDM1A/CoREST expressed in Escherichia coli using mono-methylated H3-K4 peptide as substrate assessed as H2O2 release ...More data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Xinxiang Medical University
Curated by ChEMBL
Xinxiang Medical University
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of full length LSD1 (unknown origin) expressed in Escherichia coli BL21 (DE) using H3K4me2 peptide as substrate after 30 mins by fluoresce...More data for this Ligand-Target Pair
TargetGlutathione S-transferase P/Lysine-specific histone demethylase 1A [158-852](Homo sapiens (Human))
Oryzon Genomics
US Patent
Oryzon Genomics
US Patent
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Xinxiang Medical University
Curated by ChEMBL
Xinxiang Medical University
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of human LSD1More data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Xinxiang Medical University
Curated by ChEMBL
Xinxiang Medical University
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Inhibition of recombinant LSD1 (unknown origin) expressed in Escherichia coli BL21 (DE3) using H3K4me2 peptide as substrate incubated for 30 mins by ...More data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 2(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: 1.29E+4nMAssay Description:Inhibition of KDM1B (unknown origin)More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: 4.13E+4nMAssay Description:Inhibition of recombinant human MAOA incubated for 15 mins measured after 30 mins by luminescence-Glo assayMore data for this Ligand-Target Pair
TargetLysine-specific histone demethylase 2(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: 4.35E+4nMAssay Description:Inhibition of KDM1B (unknown origin)More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: 4.84E+4nMAssay Description:Inhibition of human recombinant MAOA expressed in Pichia pastoris preincubated for 15 mins measured after 30 mins by bioluminescent-coupled assayMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] B(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human recombinant MAOB expressed in Pichia pastoris preincubated for 15 mins measured after 30 mins by bioluminescent-coupled assayMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] B(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:In order to monitor MAO enzymatic activities and/or their inhibition rate by inhibitor(s) of interest, a fluorescence-based (inhibitor)-screening ass...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMpH: 7.5 T: 2°CAssay Description:In order to monitor MAO enzymatic activities and/or their inhibition rate by inhibitor(s) of interest, a fluorescence-based (inhibitor)-screening ass...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] B(Homo sapiens (Human))
European Institute Of Oncology
Curated by ChEMBL
European Institute Of Oncology
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of [3H]dopamine uptake at striatal nerve endings by dopamine transporterMore data for this Ligand-Target Pair
